Merchant; Fahar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Merchant; Fahar.The latest application filed is for "interleukin-4 receptor-binding fusion proteins and uses thereof".

Company Profile

5.9.21

Merchant; Fahar - Vancouver CA
Merchant; Fahar - West Vancouver CA
Merchant; Fahar - Edmonton CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Interleukin-4 receptor-binding fusion proteins and uses thereof Grant 11,352,402 - Merchant , et al. June 7, 2	2022-06-07
Interleukin-4 Receptor-binding Fusion Proteins And Uses Thereof App 20220048965 - Merchant; Fahar ; et al.	2022-02-17
Interleukin-2 Fusion Proteins And Uses Thereof App 20210246183 - Merchant; Fahar	2021-08-12
Interleukin-4 receptor-binding fusion proteins and uses thereof Grant 11,084,856 - Merchant , et al. August 10, 2	2021-08-10
Uses And Methods For Oncolytic Virus Targeting Of Il-4/il-13 And Fusions Thereof App 20210238558 - Merchant; Fahar	2021-08-05
Il-13/il-4 Superkines: Immune Cell Targeting Constructs And Methods Of Use Thereof App 20210214410 - Garcia; Kenan Christopher ; et al.	2021-07-15
Il-4-fusion Formulations For Treatment Of Central Nervous System (cns) Tumors App 20200390861 - Merchant; Fahar	2020-12-17
Interleukin-2 fusion proteins and uses thereof Grant 10,781,242 - Merchant Sept	2020-09-22
Il-13 Superkine: Immune Cell Targeting Constructs And Methods Of Use Thereof App 20200095301 - Garcia; Kenan Christopher ; et al.	2020-03-26
Interleukin-4 Receptor-binding Fusion Proteins And Uses Thereof App 20190100567 - Merchant; Fahar	2019-04-04
Interleukin-4 Receptor-binding Fusion Proteins And Uses Thereof App 20190100568 - Merchant; Fahar	2019-04-04
Il-2 Superagonists In Combination With Anti-pd-1 Antibodies App 20190062395 - Merchant; Fahar ; et al.	2019-02-28
Interleukin-4 receptor-binding fusion proteins and uses thereof Grant 10,106,592 - Merchant October 23, 2	2018-10-23
Interleukin-4 receptor-binding fusion proteins and uses thereof Grant 10,093,708 - Merchant October 9, 2	2018-10-09
Use Of Human Serum Albumin To Decrease Antigenicity Of Therapeutic Proteins App 20160354472 - Merchant; Fahar	2016-12-08
Treating Cancer Stem Cells Using Targeted Cargo Proteins App 20160271231 - Merchant; Fahar	2016-09-22
Interleukin-4 Receptor-binding Fusion Proteins And Uses Thereof App 20160237135 - Merchant; Fahar	2016-08-18
Interleukin-2 Fusion Proteins And Uses Thereof App 20160229901 - MERCHANT; Fahar	2016-08-11
Interleukin-4 Receptor-binding Fusion Proteins And Uses Thereof App 20160215035 - Merchant; Fahar	2016-07-28
Treating Cancer Stem Cells Using Targeted Cargo Proteins App 20140193358 - Merchant; Fahar	2014-07-10
Treating Cancer Stem Cells Using Targeted Cargo Proteins App 20110171219 - Merchant; Fahar	2011-07-14
Process for production of diphtheria toxin Grant 7,575,891 - Wolfe , et al. August 18, 2	2009-08-18
Process for Production of Diphtheria Toxin App 20080153750 - Wolfe; Henry ; et al.	2008-06-26
Process for production diphtheria toxin Grant 7,273,728 - Wolfe , et al. September 25, 2	2007-09-25
Process for production diphtheria toxin App 20060035340 - Wolfe; Henry ; et al.	2006-02-16
Process for production diphtheria toxin Grant 6,962,803 - Wolfe , et al. November 8, 2	2005-11-08
Process for production diphtheria toxin App 20040087775 - Wolfe, Henry ; et al.	2004-05-06
Process for production diphtheria toxin Grant 6,689,871 - Wolfe , et al. February 10, 2	2004-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.